| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 7,900 | 19 May 2025 | Direct | ||
| Aptose Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 3,333 | 05 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELTX | Elicio Therapeutics, Inc. | 19 May 2025 | 1 | $0 | 4 | Director | 20 May 2025, 16:08 |
| ELTX | Elicio Therapeutics, Inc. | 21 Nov 2024 | 1 | $0 | 4 | Director | 25 Nov 2024, 07:36 |
| APTOF | Aptose Biosciences Inc. | 05 Feb 2024 | 1 | $0 | 4 | Director | 07 Feb 2024, 16:44 |
| ELTX | Elicio Therapeutics, Inc. | 28 Dec 2023 | 1 | $0 | 4 | Director | 29 Dec 2023, 17:05 |
| ELTX | Elicio Therapeutics, Inc. | 01 Jun 2023 | 0 | $0 | 3 | Director | 07 Jun 2023, 21:36 |
| APTOF | Aptose Biosciences Inc. | 19 Jan 2023 | 1 | $0 | 4 | Director | 23 Jan 2023, 18:51 |
| APTOF | Aptose Biosciences Inc. | 18 Jan 2022 | 1 | $0 | 4 | Director | 20 Jan 2022, 17:04 |